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Abstract
Background: Rabbits are currently not a good model for studying diseases of the corneal endothelium because
their corneal endothelial cells (CECs) maintain a high proliferative capacity throughout almost all their life.
Addressing this particular feature might allow the use of this species for such a purpose. The aim of this study was
to evaluate the corneal endothelial injury after intracameral benzalkonium chloride (BAC) injection into rabbit eyes
ex vivo, and to establish the most suitable starting dose for an in vivo study aimed at developing an animal model
of corneal endothelial disease.
Results: Forty rabbit eyes obtained postmortem by transconjunctival enucleation were divided into 8 groups
according to the injected compound: Control (no injection), BSS, and increasing BAC concentrations (0.005%,
0.01%, 0.025%, 0.05%, 0.1% and 0.2%). At 0, 6, 24 and 48 h, ophthalmologic examination of the anterior
segment, pachymetry and specular microscopy were performed, and corneas were finally vital-stained and
observed under the light microscope to assess the CECs morphology and mortality rate. When compared to
BSS, CECs density started to decrease significantly at 0.025% BAC concentration, while mean cell area, corneal
edema and corneal thickness began to increase significantly at 0.05%, 0.005% and 0.1% BAC concentrations,
respectively. Concentrations of 0.05% BAC and above caused significant increases in CECs pleomorphism
(decreased hexagonality) and mortality, compared to control and BSS.
Conclusions: Ex vivo intracameral BAC injection induces corneal endothelial toxicity in rabbits. However,
confirmatory in vivo studies are required to develop the desired model, with 0.05% BAC being a suggested starting
point.
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Background
The corneal endothelium (CE) is a single layer of cells on
the inner surface of the cornea, whose main function is
controlling the hydration of the cornea, thereby main-
taining its transparency. The CE has enough corneal
endothelial cells (CECs) to preserve this function
throughout life, but a reduction of CECs might occur due
to different causes, including endothelial dystrophies,
glaucoma, trauma, uveitis, surgeries and stress [1–8].
When there is a decrease in the number of CECs, the
remaining cells react increasing their size and altering
their morphology, but if cell loss is too great, these
compensatory changes are not enough and endothelial
decompensation occurs, resulting in corneal edema
and partial or complete loss of corneal transparency.
Unfortunately, the in vivo proliferative capacity of
CECs in humans, primates and small animals is very
limited [4–7].
Among the current treatments for diseases affecting
the CE in humans, several types of endothelial kerato-
plasty techniques have been described, such as Descemet
stripping (automated) endothelial keratoplasty (DSEK/
DSAEK), and Descemet membrane endothelial kerato-
plasty (DMEK). In addition, the use of cultivated CECs,
by either CECs sheet transplantation or CECs injection
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therapy combined with the application of a Rho-kinase
(ROCK) inhibitor, has been also reported [5, 9, 10].
The ideal animal model for the development of tech-
niques to repair endothelial lesions should be anatomic-
ally and physiologically similar to the human model.
Pigs, dogs and cats are commonly used animal models
in ophthalmology research, especially in retinal studies,
but they are not as commonly used in corneal research.
Several experimental animal models for the development
of a tissue-engineered CE have been described, including
pig, cat, monkey, rat, mouse and rabbit [3, 10, 11].
Because of its high availability, low cost, small size
and easy handling, rabbits are very frequently used in
research, including research in human ophthalmology
[10, 12, 13]. However, rabbits are currently not a good
model for studying diseases of the CE because their
CECs maintain a high proliferative capacity throughout
almost all of their life [6, 10, 11, 13]. Addressing this
particular feature might allow the use of this species for
such a purpose.
Benzalkonium chloride (BAC), a quaternary ammo-
nium compound, is the most commonly used preserva-
tive in ophthalmic preparations at concentrations
ranging between 0.004% and 0.025% [7, 14–19]. Topical
high BAC concentrations in rabbits, however, have toxic
effects on the cornea affecting the integrity of the CE as
well as other ocular structures. Furthermore, topical
BAC has been shown to induce tear film drying, thicken-
ing of corneal epithelium, loss of goblet cells, inflamma-
tory cell infiltration and proliferation in the conjunctiva,
and pro-apoptotic effects in conjunctival or trabecular
meshwork cells [14–17, 20–23]. In human beings, cases
of corneal toxicity have been reported after intraocular
exposure during cataract surgery to a BAC preserved
viscoelastic [4, 24] or to a balanced salt solution (BSS)
also preserved with BAC [25].
Effects of intracameral BAC injection in vivo and in
vitro have been previously reported in rabbits [8, 26], al-
though to the authors’ knowledge, the toxic effects of
intracameral BAC injection on the CE in rabbits have
not been evaluated ex vivo combining specular micros-
copy and vital staining. The aim of this study was two-
fold. Firstly, to evaluate the endothelial injury after a
BAC intracameral injection into rabbit eyes ex vivo, and
secondly, to establish the most suitable starting dose to




The study included a total of 40 rabbit eyes obtained
post-mortem by transconjunctival enucleation from 20
healthy adult rabbits (New Zealand White, New Zealand
White/California cross, New Zealand White/European
rabbit cross) of different gender, weighing 2 to 3 kg, be-
tween 8 and 12 weeks of age. Two rabbit slaughter-
houses provided the animals (Escorxador Industrial de
Conills J. Grau SL, Calaf, Barcelona, Spain; and
Mularcun SL, Xert, Castelló, Spain). Eyes were enu-
cleated immediately after sacrifice in the slaughter-
house itself. Thereafter, a pack of sterile gauzes were
introduced in a sterile container, the eye was placed
on top, and 5 mL of cooled Ringer’s lactate solution
was instilled and spread over it, creating a moist-
chamber. The container was immediately closed, iden-
tified and cold transported to the Ophthalmology
laboratory of the Veterinary School of the Universitat
Autònoma de Barcelona (UAB).
Preliminary assessment
The preliminary assessment was performed within 6 h
from enucleation, by means of slit-lamp biomicroscopy
(SL-15 Portable Slit-Lamp Biomicroscope®, Kowa Co. Ltd.,
Tokyo, Japan), specular microscopy and corneal pachyme-
try (Specular Microscope SP-2000P®, Topcon, Tokyo,
Japan). Ophthalmic examination of the cornea and anter-
ior segment was performed on all eyes in a dark room.
Only eyes with no evidence of corneal and/or anterior
segment disease were included in the study (n = 40). Eyes
were placed in a homemade methacrylate eyeball holder
and examined using the non-contact specular microscope
in an automatic mode. All procedures were performed by
the same investigator maintaining a working distance of
25 mm. Initially, eyes were excluded from the study if they
presented corneal decompensation, damaged CECs, CECs
loss, or presence of inflammatory cells on the CE. Three
microphotographs were obtained from the central area of
the cornea. Thirty well-defined CECs from each photo-
micrograph were analyzed to obtain the mean cell area
(MCA; expressed in μm2) and the endothelial cell density
(ECD; expressed in number of cells/mm2). Central corneal
thickness (CCT; expressed in μm) was measured using the
digital pachymeter of the same specular microscope in
automatic mode.
Intracameral injections
Selected eyes (n = 40) were classified into 8 groups (n = 5)
according to the substance injected: Control group
(no injection), comparison or BSS group [injection of
BSS (BSS sterile irrigation solution, Laboratoris Alcon, el
Masnou, Barcelona, Spain)], and 6 Experimental groups
(0.005%, 0.01%, 0.025%, 0.05%, 0.1% and 0.2% BAC). The
different BAC compounds used in the study were
prepared under sterile conditions (Farmàcia Xalabarder,
Barcelona, Spain), with BSS as a diluent. All intracameral
injections were performed by the same investigator at the
corneal limbus, under magnification loupes (Loupes
4×, Zeiss, Germany) and using a 27 G needle. The
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needle was removed immediately after the injection.
One or two drops of aqueous humor were allowed to
passively egress through the hub of the needle, then
0.1 mL of the appropriate compound were carefully
injected into the anterior chamber. Pressure was then
applied at the injection site with conjunctival forceps
for 20 s to avoid fluid leakage.
Post-injection assessment
Biomicroscopy, pachymetry and specular microscopy
were also performed at 6, 24 and 48 h post-injection,
following the preliminary assessment protocol. Corneal
edema was graded from 0 (absence) to + 4 (very severe)
by biomicroscopy. Throughout the experiment, eyes
were kept inside the moist chambers under refriger-
ation at 4 °C.
Vital staining of corneal endothelium
After the 48 h post-injection assessment, corneas were
excised with a 2–3 mm scleral ring, and placed endothe-
lial side up in a Teflon holder to minimize wrinkling and
distortion. Damage to CECs was determined by using
trypan blue (Trypan blue powder, Sigma-Aldrich, St Louis,
MO, USA) and alizarin red S (Alizarin red S powder,
Sigma-Aldrich, St Louis, MO, USA) vital stains, following
a protocol described elsewhere [27]. A 0.25% trypan blue
staining dilution was prepared by diluting 0.025 mg trypan
blue powder into 10 mL of 0.9% physiological saline,
and a 0.2% alizarin red staining dilution was prepared
by diluting 0.02 mg alizarin red powder into 10 mL
of 0.9% physiological saline. The pH of the preparations
was adjusted to 4.2 in order to achieve optimum dye-
laking at the intercellular borders, as described by Taylor
et al. [27]. Using this staining technique, damaged cells
become permeable to trypan blue and show deep blue
staining of their nuclei; and alizarin red allows the
visualization of intercellular borders of CECs, as they
appear stained in red [27, 28].
After the staining procedure, several radial incisions
were made on each sample in order to flatten the cornea
before its examination under the light microscope.
Corneas were then flat-mounted endothelial side up and
evaluated under the light microscope with a 40× objective
(Motic® BA210, Motic Group, Spain). For each sample,
three photographs of the central cornea at 40× were taken
(Nikon Eclipse TE 2000, Nikon Corporation, Tokyo,
Japan) and processed with image analysis software (Image
J, National Institutes of Health, Bethesda, MD, USA) to
measure the mortality rate and the degree of pleomor-
phism. In each of these images, 30 CECs were evaluated
to quantify the number of CECs which had lost their
original hexagonal shape, and used to calculate the
percentage of hexagonal CECs, or hexagonality. Regarding
CECs vitality, if the percentage of nuclei stained in blue –
indicating that CECs were devitalized– was 33% or less,
mortality was classified as Low; if this percentage was
between 34 and 66%, it was considered as Medium level
of mortality; and if the percentage of dead CECs was
67% or higher, the image was classified as showing a
High mortality level. When appropriate, 10× images
were also taken.
Statistical analysis
No formal calculation of sample size was done due to
the characteristics of the experiment (first approach to a
new experimental animal model). It was expected that 5
eyes per group would allow obtaining appropriate results
data and doing a preliminary exploration of the specific
described sections.
Results were described with routine statistical methods
and tabulated by group. Categorical and ordinal variables
were summarized with absolute frequencies and percent-
ages and mean, standard deviation (SD), and range
(minimum, maximum) were used for continuous vari-
ables. When applicable, these summaries were provided
by time-point of assessment. Percentage of hexagonality
and mortality 48 h post-injection were evaluated by one-
way ANOVA. Number of cases per group classified as
having a Low, Medium or High percentage of dead
CECs was analyzed by one-way ANOVA with a non-
parametric approach by means rank-transformation. The
analysis for longitudinal evaluation was performed using
a Generalized Estimating Equations (GEE) approach
with an estimation of within-subject correlation from
AR(1) approach. These models included group and time
as factors with baseline results of independent variable
as covariate and the estimation of effect by group was
presented by estimated means and their standard error
(SE). All statistical analyses were performed with IBM
SPSS version 20, Armonk, NY and the significance level
alpha was set at 0.05 two-tailed.
Results
Initially, the Control group (no injection) and the BSS
group were compared in order to see if injecting BSS
into the anterior chamber could alter the cornea by
itself. No significant differences (p > 0.05) were found
between these groups for any of the parameters stud-
ied over time (data not shown), therefore the BSS
group was considered to be the comparison group for
the study.
The different degrees of corneal edema detected dur-
ing the study are depicted as means in Table 1. A signifi-
cant increase in corneal edema was observed in groups
0.005%, 0.01%, 0.025%, 0.05%, 0.1% and 0.2% BAC, when
compared to the BSS group (p < 0.001).
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Specular microscopy
A total of 695 observations were obtained with the
specular microscope (Fig. 1), included in the data set,
and statistically evaluated. When compared to the BSS
group, a significant decrease in ECD in groups 0.025%
(p = 0.033), 0.05% (p = 0.007), 0.1% (p = 0.023) and 0.2%
(p = 0.004) BAC; and a significant increase in MCA in
groups 0.05% (p = 0.011) and 0.2% (p = 0.005) BAC
were seen (Fig. 2). In most of the injected eyes, both
with BSS and with increasing concentrations of BAC,
specular microscopy evaluation allowed the visualization
of holes on the CE (Fig. 3). These changes were observed
more frequently with time after injection, regardless
of the group.
Corneal pachymetry and vital-stained microscopic images
Although an increase in CCT was observed in all the
groups over time, a significant increase in CCT was only
seen in groups 0.1% (p < 0.001) and 0.2% (p = 0.016)
BAC when compared to the BSS group (Fig. 2). With
time, an increase in CCT and MCA, and a decrease in
ECD were observed (Fig. 4).
The percentages of cell hexagonality and dead CECs
seen at 48 h post-injection are summarized in Tables 2
and 3. When compared to Control and BSS groups,
significant increases were seen in CECs mortality and
pleomorphism (decrease in hexagonal cell population) with
concentrations of 0.05% BAC and above. Vital staining also
allowed the visualization of holes on the CE (Fig. 5).
Discussion
Endothelial corneal diseases can induce different degrees
of visual deprivation that may benefit from corneal
surgery. Nowadays, endothelial transplantation is the
treatment of choice for this purpose. Endothelial kerato-
plasty techniques have significantly progressed during
the last decade, DSAEK and finally DMEK being their
best examples of selectivity [5, 9, 10]. On the other hand,
research on drugs directed to improve endothelial health is
also increasing [5, 6], and gene therapy could also be
applied to corneal endothelial disease in the near future.
These research projects could clearly benefit from having a
reproducible and repeatable animal model of endothelial
disease.
Ideally, an animal model should resemble the human
disease in terms of similar response to treatment, similar
causation or similar pathophysiological phenotype [29].
In cases where there is more than one alternative,
Table 1 Degree of corneal edema after ex vivo intracameral injection of different BAC concentrations into rabbit eyes
Corneal edema 0 h Corneal edema 6 h Corneal edema 24 h Corneal edema 48 h
BSS 0 0 + 2 + 2
0.005% BAC 0 0 + 1 + 1
0.01% BAC 0 0 + 1 + 1
0.025% BAC 0 + 1 + 1 + 1
0.05% BAC 0 + 2 +3 +3
0.1% BAC 0 + 1 + 3 + 3
0.2% BAC 0 +3 + 4 + 4
[0: no edema; + 1: mild corneal edema; + 2: moderate corneal edema; + 3 severe corneal edema; + 4: very severe corneal edema]
Fig. 1 Specular microscopy images with (right) and without (left) zoom including CCT (T), ECD (CD) and MCA (AVG) values of eye 504–2 (Control
group – no injection) at time 0 h (SP-2000P specular microscope). Normal rabbit CE was visualized as a monolayer of polygonal cells of uniform
size and shape. The zoom image shows 30 well-defined selected CECs marked with white dots, which were used to obtain the MCA and ECD
Segarra et al. BMC Veterinary Research  (2018) 14:39 Page 4 of 9
researchers should select the least phylogenetically
developed animal available. Despite the persistent in vivo
CECs proliferative capacities of rabbit CE, rabbits are
frequently used as an animal model for corneal surgery,
mainly due to their size, easy handling, short vital cycles
and low cost (purchase, housing and maintenance).
Rabbits bridge the gap between the small rodent animal
models (such as the rat and the mouse) and the larger
animal models, often required for pre-clinical, transla-
tional research. In the past, partial endothelial dysfunc-
tion models have already been described using rabbits
and monkeys. Minkowski et al. developed an in vivo
model of corneal endothelial dysfunction induced by
trans-corneal cryo-injury [3]. This lesion did not select-
ively affect the CE, but it involved the entire cornea
instead. Moreover, within a few days, the CE recovered
from the injury. Other models involving CECs scraping
have also been described in rabbits and monkeys [5, 6,
30], but surgical intraocular intervention was needed. A
CE dysfunction model induced by intracameral injection
would consequently represent an easier, cheaper and
more repeatable procedure to perform. The results of
the present study lead to the speculation that rabbits
treated with intracameral BAC could become a suitable
model for controlled pre-clinical studies aimed at evalu-
ating the efficacy of novel therapies for managing dis-
eases of the CE.
Several in vivo and in vitro procedures have been
described to assess the function and structure of the CE,
such as pachymetry, specular microscopy, endothelial
vital staining, biomicroscopy, histopathology, and scan-
ning and transmission electron microscopy [8, 10, 23,
27, 31]. Pachymetric measurements reflect the ability of
the CE to maintain corneal thickness and dehydration,
whereas specular microscopy allows characterization of
the CE. The TOPCON SP-2000P® specular microscope
provides pachymetric measurements and specular
microscopy simultaneously, and gives repeatable and
reproducible values for ECD and MCA [32, 33]. In the
present study, this device provided clear images of the
CE in healthy and mildly abnormal corneas, but obtain-
ing adequate images from moderately to severely edema-
tous corneas was not possible, as it also occurred
previously in human studies [33]. In those eyes, vital
staining was decisive for the final CE evaluation. As
previously described [27, 28], the combined staining of
devitalized cells with trypan blue, together with delinea-
tion of healthy cells with alizarin red, allowed a good
visualization of both damaged and undamaged CECs.
In our study we confirmed that, as reported by Taylor
et al. [27], adjusting the pH of the alizarin red prep-
aration to 4.2 was of critical importance in order to
ensure its effectiveness.
Due to its good safety and efficacy profile, BAC is the
most commonly used preservative in ophthalmic prepa-
rations. However, long-term use of topical drugs with
BAC may damage the cornea [14, 16, 19]. The toxic
effect of topical BAC on the ocular surface has been
reported by different authors, mainly affecting the cor-
neal epithelium and stroma [14, 15, 17, 18]. Although
Fig. 2 Mean CCT (μm), ECD (number of CECs/mm2) and MCA (μm2)
found in rabbit eyes from the different experimental groups. Columns
marked with an asterisk (*) represent groups that showed statistically
significant differences compared to the BSS group
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there are some reports on the toxic effect of topical BAC
on the CE in rats [18] and rabbits [14, 23], the studies in
rabbits so far have shown some conflicting results. Chen
et al. reported an increased CCT, without affecting ECD,
after topical application of 0.1% BAC twice daily for four
days in an in vivo model [14], whereas Green et al. found
no damage to the CE after topical application of 0.133%
BAC on deepithelialized corneas [23]. The results of both
studies indicate that topical BAC rarely affects the CE
unless administered at high and repeated doses and, in
such cases, other superficial corneal and/or conjunctival
toxic alterations may also appear [14, 15, 17, 18]. As re-
ported previously [26] and confirmed in the herein report,
the threshold for CECs BAC-induced intraocular toxicity
is lower than when applied topically, thus allowing a more
selective damage to the CE using a lower BAC concentra-
tion. Therefore, the intracameral administration could be
considered the route of choice for inducing a rabbit model
of corneal endothelial disease through selective destruction
of CECs. This would be a relatively easy technique to
obtain a model for studying diseases of the CE in a
species like the rabbit which, as stated previously, is
very convenient in many aspects for performing pre-
clinical studies.
The results of the present study establish a direct rela-
tionship between intracameral BAC concentrations and
Fig. 3 Specular microscopy images of eyes 602–2 (a) and 604–2 (b), 6 h after injection of 0.025% BAC, showing the presence of CE holes (arrows)
(SP-2000P specular microscope)
Fig. 4 Specular microscopy images including CCT (T), ECD (CD) and MCA (AVG) of eye 803–2 (0.005% BAC) at time 0 (a), 6 (b), 24 (c) and 48 (d)
hours (SP-2000P specular microscope). During the subsequent assessments, an increase in CCT and MCA, and a decrease in ECD were seen
Segarra et al. BMC Veterinary Research  (2018) 14:39 Page 6 of 9
CCT, degree of corneal edema, endothelial mortality and
endothelial pleomorphism; and an inverse relationship
between intracameral BAC concentrations and ECD and
CECs hexagonality. These relationships can be explained
by the increase in CCT produced by the reduction in
ECD induced, in turn, by the toxic effect of intracameral
BAC. The dose dependent increase in MCA can also be
explained by the toxicity of intraocular BAC.
Although there are some previous studies on the ef-
fects of intracameral BAC on CCT, corneal edema, ECD
and MCA [8, 26, 34], there are no reports on the effects
on mortality rate, pleomorphism and the presence of
endothelial holes. The increase in CCT and corneal
edema, found in response to increasing intraocular con-
centrations of BAC in the present study, is in line with
the results of two previously reported studies in rabbits
[8, 26]. Although a higher mean CCT was achieved with
0.05% BAC, compared to 0.1% BAC, the 0.05% group
did not reach the level of statistical significance probably
due to a high standard deviation within the measure-
ments. Moreover, increases in CCT and MCA, together
with a decreased ECD, have also been reported in
human patients with corneal toxicity secondary to BAC
preserved viscoelastic material or BSS used during
cataract surgery [24, 25, 34]. The mortality rate in-
creased significantly with higher BAC concentrations,
which may have induced a secondary increase in MCA
and reduction in hexagonality. Endothelial holes were
observed by both specular microscopy and vital staining,
which rules out a manipulation artefact during the stain-
ing procedure as a possible explanation, and yields the
BAC toxic effect as the most probable cause. It is im-
portant to mention that in this study the procedure of
intracameral injection did not alter the CE, as confirmed
by the lack of significant differences between the Control
and BSS groups for any of the studied parameters.
Britton et al. defined the threshold for intraocular irri-
tation induced by intracameral BAC injection as 0.03%,
based on alterations that occurred in a dose-response
manner (conjunctivitis, flare, iritis, and corneal changes)
[26]. Despite drawing this conclusion only from varia-
tions observed in ophthalmic examination and pachy-
metric measurements, this threshold is similar to 0.05%
BAC, which was the minimum concentration needed in
the present study to cause significant endothelial damage.
Our statement, however, is also supported by objective
measurements obtained through evaluations using specular
microscopy and vital staining, which further characterize
Table 2 Mean, Standard deviation (SD), minimum (Min) and maximum (Max) values for the percentage of hexagonality in each
study group 48 h post-injection
Mean SD Min Max p-value vs. Control group p-value vs. BSS group
Control group 64.0 5.18 55.0 67.8 – –
BSS group 66.8 6.04 61.7 75.6 0.758 –
0.005% BAC 43.6 7.47 31.7 52.2 0.031 0.015
0.01% BAC 59.95 11.07 44.2 70.0 0.674 0.478
0.025% BAC 71.0 4.78 65.8 77.2 0.467 0.661
0.05% BAC 10.7 23.84 0 53.3 < 0.001 < 0.001
0.1% BAC 12.0 26.83 0 60.0 < 0.001 < 0.001
0.2% BAC 0 0 0 0 < 0.001 < 0.001
The level of statistical significance (p-value) for the values of each group compared to the Control group (no injection) and the BSS group is also shown. Bold text
indicates a statistically significant difference with a p-value less than 0.01
Table 3 Number of cases per group (n = 5) classified as having a low (0–33%), medium (34–66%) or high (67–100%) percentage of
dead CECs 48 h post-injection
Low Medium High p-value vs. Control group p-value vs. BSS group
Control group 5 0 0 – –
BSS group 5 0 0 1.000 –
0.005% BAC 4 1 0 0.423 0.423
0.01% BAC 3 1 0 0.346 0.346
0.025% BAC 4 1 0 0.423 0.423
0.05% BAC 1 0 4 < 0.001 < 0.001
0.1% BAC 0 0 3 < 0.001 < 0.001
0.2% BAC 0 0 5 < 0.001 < 0.001
The level of statistical significance (p-value) for the values of each group compared to the Control group (no injection) and the BSS group is also shown. Bold text
indicates a statistically significant difference with a p-value less than 0.01
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mortality rate and morphologic changes induced by BAC
toxicity.
The results of the present ex vivo study yield that the
most suitable starting dose to develop a repeatable and
reproducible in vivo model of endothelial disease in rab-
bits is 0.1 mL of 0.05% BAC. The toxic action of BAC
would counteract the proliferative capacity of rabbit
CECs, hence making this species more suitable for such
a model. Higher BAC concentrations were associated
with a rapid and intense corneal edema and a complete
destruction of CECs in the present ex vivo study; which
in an in vivo study could be associated to severe intraoc-
ular inflammation. Nevertheless, direct extrapolations to
live animals or to other species should not be made.
Conclusions
The present study reports the endothelial injury induced
after intracameral injection of different BAC concentrations
into rabbit eyes ex vivo; thus, encouraging its use for the
development of an in vivo animal model of endothelial
disease, and establishing 0.05% BAC as the most suitable
starting dose for this purpose. These findings also provide
additional information about the toxic effect of BAC on the
cornea.
Abbreviations
BAC: Benzalkonium chloride; BSS: balanced salt solution; CCT: Central
corneal thickness; CE: corneal endothelium; CECs: corneal endothelial
cells; DMEK: Descemet membrane endothelial keratoplasty;
DSAEK: Descemet stripping automated endothelial keratoplasty;
Fig. 5 Trypan blue (nuclei of devitalized CECs stained in blue) and alizarin red (staining intercellular borders of CECs in red) vital-stained images of
eyes from the study obtained under the light microscope 48 h post-injection. a. 40× image of eye 501–2 (Control group – no injection) showing no
trypan blue staining; (b). 40× image of eye 101–2 (BSS group) showing no trypan blue staining. A giant cell can be observed in the picture (arrow); (c).
40× image of eye 805–2 (0.05% BAC) showing trypan blue staining of some CECs and less defined CECs borders; (d). 40× image of eye 203 (0.1% BAC)
showing trypan blue staining of the totality of CECs and a CE hole (arrow); (e). 10× image of eye 603–2 (0.025% BAC): CECs can easily be appreciated
and trypan blue staining of some CECs is shown; (f). 10× image of eye 203 (0.1% BAC) showing some CE holes (arrows)
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DSEK: Descemet stripping endothelial keratoplasty; ECD: endothelial
cell density; GEE: Generalized Estimating Equations; MCA: mean
cell area; ROCK: Rho-kinase; SD: standard deviation; SE: standard error;
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